SCHEMBL19628142

SCHEMBL19628142

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc4cccc5c6c7ccccc7sc6c6cccc3c6c45)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
TNKS O95271 2/20 0.34
TNKS2 Q9H2K2 2/20 0.34
ALOX5 P09917 1/20 0.34
MAPT P10636 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
TSHR P16473 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ATM Q13315 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19628140 0.88 MEN1 (0.38) TNKSTNKS2ALOX5MAPTL3MBTL1
SCHEMBL14882844 0.86 TNKS (0.37) ADORA2AADORA1TNKSTNKS2ALOX5
SCHEMBL19628146 0.84 TNKS (0.35) TNKSTNKS2ALOX5MAPTL3MBTL1
SCHEMBL26472873 0.84 ALOX5 (0.39) ADORA2AADORA1TNKSTNKS2ALOX5
SCHEMBL19628178 0.83 MEN1 (0.35) TNKSTNKS2ALOX5MAPTL3MBTL1
SCHEMBL19628175 0.83 PTPN1 (0.37) TNKSTNKS2ALOX5MAPTL3MBTL1
SCHEMBL26473449 0.83 ALOX5 (0.36) ADORA2AADORA1TNKSTNKS2ALOX5
SCHEMBL24275444 0.82 TNKS (0.36) ADORA2AADORA1TNKSTNKS2ALOX5
SCHEMBL25112893 0.82 ALDH1A1 (0.44) ADORA2AADORA1MAPTL3MBTL1TSHR
SCHEMBL26472223 0.82 TNKS (0.38) ADORA2AADORA1TNKSTNKS2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439144-B2 Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device UNIVERSITY-INDUSTRY COOPERATEON GROUP OF KYUNG HEE UNIVERSITY (KR) 2019-10-08 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439144-B2 Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device OR10J3, OCIAD2, OCIAD1 ADORA2A 4313/4885ADORA1 4009/4885TNKS 4514/4885
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 ADORA2A 4313/4885ADORA1 4009/4885TNKS 4514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.